Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Bayer (Norway)
h-index: 39
Total citations: 6,964
Total papers: 188
Homepage:
http://www.bayer.no/
Recent papers from Bayer (Norway)
Application of artificial intelligence in non-invasive cardiovascular imaging for coronary artery disease: a systematic review and meta-analysis
Frontiers in Cardiovascular Medicine · 2025
Multiomics Comparison of Proline‐Rich Peptide‐Enhanced Hyaluronic Acid Gels Versus Conventional Regenerative Materials: An Early Wound‐Healing Model
Journal of Periodontal Research · 2025
Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up
European Journal of Nuclear Medicine and Molecular Imaging · 2025
Designing and implementing healthcare technology for rehabilitation processes—a wicked problem? Lessons learned from a collaboration between healthcare personnel and technologists
Digital Health · 2025
Neural correlates of image memorability: Combining large-scale 7T fMRI with machine learning-based predictions
2025
Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the USA: A Cohort Study from the FOUNTAIN Platform
The Nephron journals/Nephron journals · 2025
Treatment Patterns, Adverse Events, and Clinical Outcomes with Steroidal Mineralocorticoid Receptor Antagonists: A Retrospective Analysis of Administrative Claims Data (RELICS)
Pragmatic and Observational Research · 2025
Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study
Diabetes Therapy · 2024
FOUNTAIN: a modular research platform for integrated real-world evidence generation
BMC Medical Research Methodology · 2024
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer
Clinical Cancer Research · 2024
Abstract ND09: Actinium-225 -PSMA-Trillium (BAY 3563254): Preclinical evaluation and clinical imaging study of a novel 225Ac-labeled PSMA-targeting small molecule triad for the treatment of mCRPC
Cancer Research · 2024
Abstract 6033: Preclinical evaluation of an actinium-225 labeled PSMA-targeting small molecule (225Ac-PSMA-Trillium (BAY 3563254)) for the treatment of metastatic castration resistant prostate cancer (mCRPC)
Cancer Research · 2024
Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models
European Journal of Nuclear Medicine and Molecular Imaging · 2023
Characteristics of patients with chronic kidney disease and Type 2 diabetes initiating finerenone in the USA: a multi-database, cross-sectional study
Journal of Comparative Effectiveness Research · 2023
Efficacy of a HER2-Targeted Thorium-227 Conjugate in a HER2-Positive Breast Cancer Bone Metastasis Model
Cancers · 2023
Targeted thorium-227 conjugates as treatment options in oncology
Frontiers in Medicine · 2023
Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model
Frontiers in Medicine · 2022
89Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted 227Th-conjugate therapy in mice
Journal of Nuclear Medicine · 2022
Characteristics, treatment patterns, and residual cardiovascular risk of patients with a first acute myocardial infarction: A nationwide population‐based cohort study in Norway
Fundamental and Clinical Pharmacology · 2021
Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy
Journal for ImmunoTherapy of Cancer · 2021